Free Trial

Surrozen (SRZNW) Competitors

$0.02 0.00 (0.00%)
As of 04/17/2025

SRZNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Surrozen vs.

Surrozen (NASDAQ:SRZNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Surrozen and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
SurrozenN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$10.66MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Surrozen's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Surrozen Neutral
180 Life Sciences Neutral

Summary

Surrozen beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRZNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRZNW vs. The Competition

MetricSurrozenBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$122.22M$5.31B$7.35B
Dividend YieldN/A3.82%5.47%4.31%
P/E RatioN/A3.0521.9417.82
Price / SalesN/A4,230.36380.9497.72
Price / CashN/A13.2238.3134.64
Price / BookN/A34.746.453.98
Net IncomeN/A-$93.04M$3.22B$247.81M
7 Day PerformanceN/A2.19%5.85%3.19%
1 Month PerformanceN/A-5.51%-9.58%-7.70%
1 Year PerformanceN/A85.44%11.85%1.49%

Surrozen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRZNW
Surrozen
N/A$0.02
flat
N/AN/A$0.00$10.66M0.0080
ATNFW
180 Life Sciences
N/A$0.01
-2.6%
N/A-12.2%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+2.5%
N/A-80.5%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.08
-2.4%
N/A+97.8%$0.00$20,729.000.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.11
-14.6%
N/A-68.4%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.07
+7.7%
N/AN/A$0.00$37.32M0.0070Positive News
BTMDW
biote
N/A$0.02
-34.7%
N/AN/A$0.00$197.19M0.00N/AGap Down
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.09
flat
N/A-93.1%$0.00N/A0.008Positive News
Gap Down
CELUW
Celularity
N/A$0.04
-0.3%
N/A+1.0%$0.00$48.20M0.00220Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:SRZNW) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners